Therese Hultstrand is an author at AstraZeneca (Sweden) specializing in diabetes, medicine, and cardiovascular disease.
Top concepts
HealthObesityDiabetesMedicineMetabolismPhysiologyPharmacologyBody CompositionMetabolic HealthInsulin Resistance
Publications per year
2005–2005
1
1
Tesaglitazar, a dual PPARα/γ agonist, ameliorates glucose and lipid intolerance in obese Zucker rats
Nicholas D. Oakes, Pia Thalén, Therese Hultstrand et al. · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · 2005 · 36 citations
Metabolic Disorder, Glucose Tolerance, Insulin Signaling +18
Rows per page
1–1 of 1